Literature DB >> 3095364

Enzyme-linked immunosorbent assay with major outer membrane proteins of Brucella melitensis to measure immune response to Brucella species.

S B Hunter, W F Bibb, C N Shih, A F Kaufmann, J R Mitchell, R M McKinney.   

Abstract

We developed an enzyme-linked immunosorbent assay (ELISA) system to measure human immunoglobulin G (IgG) and IgM response to the major outer membrane proteins of Brucella melitensis. The ELISA was more sensitive in detecting antibody than a standard microagglutination (MA) test with B. abortus antigen. Of 101 sera from persons with suspected brucellosis, 79 (78.2%) gave ELISA IgM titers greater than or equal to the B. abortus MA titer without 2-mercaptoethanol (2ME), which measures both IgM and IgG. Of the 101 sera, 97% gave ELISA IgG titers greater than or equal to the MA with 2ME titer. A total of 58 sera, drawn from 11 human patients from 1 to 29 weeks after onset of brucellosis, gave higher geometric mean titers for the ELISA IgG test than for the MA with 2ME test. These 58 sera also gave ELISA IgM geometric mean titers that were greater than or within one doubling dilution of the geometric mean titers of MA without 2ME. In addition to detecting antibody response to B. abortus, B. melitensis, and B. suis, the ELISA was sensitive to antibody response to human and canine infections with B. canis. The B. canis antibody response is not detected by the MA test with B. abortus antigen. The ELISA, with a standard preparation of major outer membrane proteins of B. melitensis as antigen, appears to be useful in measuring antibody response in humans to infections by all species of Brucella known to infect humans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3095364      PMCID: PMC268973          DOI: 10.1128/jcm.24.4.566-572.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  SIGNIFICANCE OF 7S AND MACROGLOBULIN BRUCELLA AGGLUTININS IN HUMAN BRUCELLOSIS.

Authors:  J L REDDIN; R K ANDERSON; R JENNESS; W W SPINK
Journal:  N Engl J Med       Date:  1965-06-17       Impact factor: 91.245

2.  Characterization of the major envelope protein from Escherichia coli. Regular arrangement on the peptidoglycan and unusual dodecyl sulfate binding.

Authors:  J P Rosenbusch
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

3.  Microtiter plate agglutination test for Brucella canis antibodies.

Authors:  S C Damp; M H Crumrine; G E Lewis
Journal:  Appl Microbiol       Date:  1973-03

4.  Detoxification and immunogenic properties of endotoxin-containing precipitate of Brucella abortus.

Authors:  F F Badakhsh; J W Foster
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

5.  Human infection with Brucella canis.

Authors:  R M Swenson; L E Carmichael; K R Cundy
Journal:  Ann Intern Med       Date:  1972-03       Impact factor: 25.391

6.  Techniques and interpretations in the serological diagnosis of brucellosis in man.

Authors:  W R Kerr; W J McCaughey; J D Coghlan; D J Payne; R A Quaife; L Robertson; I D Farrell
Journal:  J Med Microbiol       Date:  1968-11       Impact factor: 2.472

7.  Seroepidemiological investigation of Brucella canis antibodies in different human population groups.

Authors:  P W Monroe; S L Silberg; P M Morgan; M Adess
Journal:  J Clin Microbiol       Date:  1975-11       Impact factor: 5.948

8.  Enzyme-linked immunosorbent assay for bovine immunoglobulin subclass-specific response to Brucella abortus lipopolysaccharides.

Authors:  V L Lamb; L M Jones; G G Schurig; D T Berman
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

9.  Enzyme-linked immunosorbent assay (ELISA) for titration of antibodies against Brucella abortus and Yersinia enterocolitica.

Authors:  H E Carlsson; B Hurvell; A A Lindberg
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-06

10.  Radioimmunoassay of IgM, IgG, and IgA Brucella antibodies.

Authors:  D Parratt; K H Nielsen; R G White
Journal:  Lancet       Date:  1977-05-21       Impact factor: 79.321

View more
  7 in total

1.  Determination by enzyme-linked immunosorbent assay of immunoglobulin G (IgG), IgM, and IgA to Brucella melitensis major outer membrane proteins and whole-cell heat-killed antigens in sera of patients with brucellosis.

Authors:  G F Araj; A F Kaufmann
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

2.  Generation, characterization and crystallization of a cytochrome c(1)-subunit IV fused cytochrome bc(1) complex from Rhodobacter sphaeroides.

Authors:  Ting Su; Lothar Esser; Di Xia; Chang-An Yu; Linda Yu
Journal:  Biochim Biophys Acta       Date:  2011-10-25

3.  Analysis of 506 consecutive positive serologic tests for brucellosis in Saudi Arabia.

Authors:  F W Kiel; M Y Khan
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

4.  Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production.

Authors:  V Weynants; J Godfroid; B Limbourg; C Saegerman; J J Letesson
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

5.  Development and comparative evaluation of a plate enzyme-linked immunosorbent assay based on recombinant outer membrane antigens Omp28 and Omp31 for diagnosis of human brucellosis.

Authors:  Sapana Tiwari; Ashu Kumar; Duraipandian Thavaselvam; Smita Mangalgi; Vedika Rathod; Archana Prakash; Anita Barua; Sonia Arora; Kannusamy Sathyaseelan
Journal:  Clin Vaccine Immunol       Date:  2013-06-12

6.  False positive seroreactivity to brucellosis in tuberculosis patients: a prevalence study.

Authors:  Mojtaba Varshochi; Jafar Majidi; Marjan Amini; Kamyar Ghabili; Mohammadali M Shoja
Journal:  Int J Gen Med       Date:  2011-03-14

7.  Immunoblot studies in the differential diagnosis of porcine brucellosis: an immunodominant 62 kDa protein is related to the mycobacterial 65 kDa heat shock protein (HSP-65).

Authors:  S A Spencer; E S Broughton; S Hamid; D B Young
Journal:  Vet Microbiol       Date:  1994-03       Impact factor: 3.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.